Concentrations of echinocandins in ascites, pleural effusion, bile, wound secretion and cerebrospinal fluid – a pilot study

Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin I0 个研究点目标入组 126 人开始时间: 2013年12月16日最近更新: 2015年7月10日

适应症

试验速览

暂无简介。

•Age of 18 years or over
•Running echinocandin therapy (caspofungin, micafungin or anidulafungin) within the last 30 days
•Indication for paracentesis (or peritoneal drainage), thoracentesis (or pleural drainage), lumbar puncture, bile deviation (via drainage or T-tube) or sampling by endoscopy or VAC® therapy
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 126
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 126

•Lacking indication for echinocandin therapy
•Contraindication for echinocandin therapy
•Lacking indication or contraindication for paracentesis (or peritoneal drainage), thoracentesis (or pleural drainage), lumbar puncture, bile deviation (via drainage or T-tube) or sampling by endoscopy or VAC® therapy
•Age below 18 years
•Lacking consent of a competent patient, lacking post-hoc consent of a patient who had been incompetent at the time of sampling and has gained competence (In the latter case the respective data will not be used.)

发起方

Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin I